SCHEMBL22972243

SCHEMBL22972243

N#Cc1ccc(CNI)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 2/20 0.65
CYP2A6 P11509 2/20 0.52
CYP19A1 P11511 2/20 0.52
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAOB P27338 4/20 0.44
MAOA P21397 3/20 0.44
KDM1A O60341 1/20 0.44
SAE1 Q9UBE0 1/20 0.43
UBA2 Q9UBT2 1/20 0.43
CA12 O43570 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
CA1 P00915 1/20 0.42
CA4 P22748 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23879203 0.81 LOXL2 (0.71) LOXL2CYP2A6CYP19A1ALDH1A1KDM4E
SCHEMBL25588079 0.79 LOXL2 (0.68) LOXL2CYP2A6CYP19A1ALDH1A1KDM4E
SCHEMBL509578 0.79 LOXL2 (1.00) LOXL2CYP2A6CYP19A1ALDH1A1KDM4E
SCHEMBL13181792 0.77 LOXL2 (0.65) LOXL2CYP2A6CYP19A1ALDH1A1KDM4E
SCHEMBL6248112 0.77 LOXL2 (0.65) LOXL2CYP2A6CYP19A1ALDH1A1KDM4E
SCHEMBL11626791 0.77 LOXL2 (0.65) LOXL2CYP2A6CYP19A1ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL8135282 0.77 LOXL2 (0.95) LOXL2CYP2A6CYP19A1ALDH1A1KDM4E
SCHEMBL29912750 0.77 LOXL2 (0.65) LOXL2CYP2A6CYP19A1ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL6761490 0.76 LOXL2 (0.63) LOXL2CYP2A6CYP19A1ALDH1A1KDM4E
SCHEMBL5992317 0.76 LOXL2 (0.63) LOXL2CYP2A6CYP19A1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365511-A1 Antiviral Pyrazolopiridinone Compounds NOVARTIS AG (CH) 2023-11-16 US disclosed
WO-2021023888-A1 ISOQUINOLINE DERIVATIVES AS PROTEIN KINASE INHIBITORS B.C.I. PHARMA (BE) 2021-02-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365511-A1 Antiviral Pyrazolopiridinone Compounds ZC3HAV1, ZC3HAV1L, RPL35 LOXL2 4676/4885CYP2A6 759/4885CYP19A1 1049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.